Loading…
NeuroOne Medical Technologies Corporation is projected to rise to $1.74 by 2027, a +2% move from its current price of $1.70. NMTC is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $1.64 | $1.70 | $1.77 | 0.00% |
| Aug 6 | $1.61 | $1.70 | $1.80 | 0.00% |
| Aug 7 | $1.59 | $1.70 | $1.82 | 0.00% |
| Aug 8 | $1.57 | $1.70 | $1.84 | 0.00% |
| Aug 9 | $1.56 | $1.70 | $1.85 | 0.00% |
| Aug 10 | $1.55 | $1.70 | $1.87 | 0.00% |
| Aug 11 | $1.54 | $1.70 | $1.88 | 0.00% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.54 | $1.70 | $1.88 | 0.00% |
| Week 2 | $1.47 | $1.70 | $1.96 | 0.00% |
| Week 3 | $1.43 | $1.70 | $2.03 | +0.01% |
| Week 4 | $1.39 | $1.70 | $2.08 | +0.01% |
| Week 5 | $1.35 | $1.70 | $2.13 | +0.01% |
| Week 6 | $1.33 | $1.70 | $2.18 | +0.01% |
| Week 7 | $1.30 | $1.70 | $2.23 | +0.01% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
NeuroOne Medical Technologies Corporation is a medical technology company that provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States.
The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders.
The company is based in Eden Prairie, Minnesota, and collaborates with the Department of Neurology's Division of Epilepsy at the University of Minnesota Medical School to advance a study evaluating epilepsy therapies.
NeuroOne Medical Technologies Corporation (NMTC) is a healthcare stock with a current price of $1.76 and a market cap of $15.32M. It is ranked 4774 in total market capitalization. The stock carries an annual volatility of 80% and exhibits a mixed near-term technical picture with a long-run bullish forecast as reflected in the year-by-year price projections.
Forecasts show a gradual, upside-biased path from 2026 through 2050, with 2026 at a neutral starting point and substantial upside by the late 2030s and into 2050. The long-run averages rise from the mid-2 dollar range to about $6.12 by 2050, implying meaningful upside despite near-term volatility.
A major floor 68.8% below — a decisive break under it would weaken the trend.
Price is testing support right now (2.9% away) — a key level to hold.
The nearest ceiling, 97.1% above — a clean break opens room to run.
A major ceiling 200.6% above — clearing it would confirm fresh momentum.
Key NMTC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NMTC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.69 | Buy | $1.73 | Sell |
| MA 10 | $1.84 | Sell | $1.88 | Sell |
| MA 20 | $2.27 | Sell | $2.20 | Sell |
| MA 50 | $2.96 | Sell | $2.86 | Sell |
| MA 100 | $3.77 | Sell | $3.45 | Sell |
| MA 200 | $4.18 | Sell | $3.97 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 21.12 | Buy |
| Stoch RSI (14) | 25.54 | Neutral |
| CCI (20) | -89.09 | Neutral |
| Williams %R (14) | -95.35 | Info |
| MACD (12,26,9) | -0.02 | Sell |
| ROC (12) | -32.67 | Sell |
| Bollinger %B (20,2) | 0.20 | Neutral |
| Stochastic %K (14) | 4.65 | Buy |
| TRIX (15) | -1.90 | Sell |
| Awesome (5,34) | -0.97 | Sell |
| Ultimate (7,14,28) | 20.07 | Buy |
| Momentum (10) | -0.65 | Sell |
| Aroon Osc (25) | -84.00 | Sell |
| Hull MA (9) | 1.61 | Buy |
| ADX (14) | 47.04 | Sell |
| ATR (14) | 0.09 | Info |
The 30-day technical picture is neutral, with current sentiment labeled NEUTRAL.
RSI14 is 20, suggesting the stock is in oversold territory for a near-term bounce potential. The 50-day simple moving average sits at $3.23 and the 200-day simple moving average sits at $4.29, indicating the price is below both major moving averages.
Support is at $1.76 and resistance is at $3.35. The 30-day price range spans from $1.35 to $2.30, highlighting the recent narrow trading window and potential for a move toward the nearby support or resistance levels.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.65 | $1.70 | $2.28 | 0% | Neutral | |
| $1.34 | $1.74 | $2.42 | +2% | Neutral | |
| $1.75 | $2.37 | $3.47 | +39% | Bullish | |
| $1.73 | $2.43 | $3.70 | +43% | Bullish | |
| $1.48 | $2.14 | $3.36 | +26% | Bullish | |
| $1.50 | $2.23 | $3.61 | +31% | Bullish | |
| $1.38 | $2.11 | $3.50 | +24% | Bullish | |
| $1.40 | $2.20 | $3.73 | +29% | Bullish | |
| $1.70 | $2.74 | $4.73 | +61% | Bullish | |
| $1.76 | $2.91 | $5.12 | +71% | Bullish | |
| $1.83 | $3.37 | $6.41 | +98% | Bullish | |
| $2.58 | $5.73 | $12.19 | +237% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $1.65 | $1.70 | $2.16 | +0.00% |
| September 2026 | $1.46 | $1.74 | $2.16 | +2.42% |
| October 2026 | $1.41 | $1.70 | $2.14 | -2.33% |
| November 2026 | $1.45 | $1.77 | $2.25 | +3.95% |
| December 2026 | $1.45 | $1.78 | $2.28 | +0.45% |
Click any year to see its month-by-month NMTC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The NMTC price prediction for 2026 points to an average of $1.70 (low $1.65, high $2.28) — a potential gain of 0% on today's $1.70. A consolidation phase looks the most probable path here.
In 2027, NMTC is projected to trade between $1.34 and $2.42, averaging $1.74 — a potential gain of +2% from today's $1.70. That is up +2% on the projected 2026 average. Price action looks broadly range-bound.
NeuroOne Medical Technologies Corporation's 2028 outlook centres on $2.37, within a $1.75 to $3.47 range. That is up +36% on the projected 2027 average. That marks a +39% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, NMTC could reach as high as $3.70, with a base case around $2.43 and support toward $1.73 — roughly +43% from $1.70. Momentum favours further upside here.
Expect NMTC to range from $1.48 to $3.36 through 2030. The $2.14 average target implies a +26% move from current prices. That is -12% versus the projected 2029 average. Buyers look set to stay in control over this stretch.
The NMTC price prediction for 2031 points to an average of $2.23 (low $1.50, high $3.61) — a potential gain of +31% on today's $1.70. Momentum favours further upside here.
In 2032, NMTC is projected to trade between $1.38 and $3.50, averaging $2.11 — a potential gain of +24% from today's $1.70. That is -5% versus the projected 2031 average. Buyers look set to stay in control over this stretch.
NeuroOne Medical Technologies Corporation's 2033 outlook centres on $2.20, within a $1.40 to $3.73 range. That is up +4% on the projected 2032 average. That marks a +29% change versus current levels. Momentum favours further upside here.
By 2034, NMTC could reach as high as $4.73, with a base case around $2.74 and support toward $1.70 — roughly +61% from $1.70. Buyers look set to stay in control over this stretch.
Expect NMTC to range from $1.76 to $5.12 through 2035. The $2.91 average target implies a +71% move from current prices. That is up +6% on the projected 2034 average. Momentum favours further upside here.
The NMTC price prediction for 2040 points to an average of $3.37 (low $1.83, high $6.41) — a potential gain of +98% on today's $1.70. Buyers look set to stay in control over this stretch.
In 2050, NMTC is projected to trade between $2.58 and $12.19, averaging $5.73 — a potential gain of +237% from today's $1.70. That is up +70% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in NMTC today (≈ 588.235294 NMTC) could be worth
$3,369.11
+$2,369.11 (+237%) by 2050 · US Dollar
Based on the average projected NMTC price of $5.73 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NMTCwould be worth at today's price.
$1,000 invested in NMTC on Jul 31, 2025 (≈ 213.128734 NMTC) would be worth
$362.32
-$637.68 (-63.8%) today · 0.36× · US Dollar
Based on a NMTC entry price of $4.69 vs. today's $1.7.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.9 | $894.74 | -10.5% |
| 1 month ago | $3 | $566.67 | -43.3% |
| 3 months ago | $4.35 | $390.8 | -60.9% |
| 6 months ago | $5.01 | $339.32 | -66.1% |
| 1 year ago | $4.69 | $362.32 | -63.8% |
| All time (5.0y) ago | $28.2 | $60.28 | -94.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NMTC forecast.
Our base-case forecast reaches $3.40 around 2050.
Implied market cap at $3.40: $29.59M
The multi-year forecast outlines a bullish trajectory across the later years, with the following year-by-year snapshot: 2026 min $1.76, avg $1.76, max $2.37, ROI 0; 2027 min $1.41, avg $1.84, max $2.59, ROI 4.8; 2028 min $1.87, avg $2.56, max $3.80, ROI 45.6; 2029 min $1.80, avg $2.57, max $3.96, ROI 45.9; 2030 min $1.53, avg $2.24, max $3.58, ROI 27.5; 2031 min $1.58, avg $2.40, max $3.93, ROI 36.1; 2032 min $1.43, avg $2.22, max $3.75, ROI 26.4; 2033 min $1.46, avg $2.35, max $4.04, ROI 33.4; 2034 min $1.83, avg $3.01, max $5.29, ROI 70.8; 2035 min $1.85, avg $3.12, max $5.59, ROI 77; 2040 min $1.97, avg $3.74, max $7.28, ROI 112.8; 2050 min $2.75, avg $6.12, max $13.33, ROI 247.5.
Sentiment shifts to BULLISH from 2028 onward, with the long-term highs driven by higher average prices and the substantial upside projected for 2040 and 2050. These figures are estimates and not guarantees of future performance; actual results will vary with market conditions and company fundamentals.
Tap a question to reveal the answer.
2030 avg price is $2.24, with a min of $1.53 and a max of $3.58. The projected ROI for 2030 is 27.5%, and the sentiment is BULLISH.
The forecast shows a bullish trajectory from 2028 onward, with notable upside in later years: 2034 max $5.29 (70.8% ROI) and 2040 max $7.28 (112.8% ROI), culminating in 2050 max $13.33 (247.5% ROI). Near-term years 2026–2027 are more modest (ROI 0% in 2026, 4.8% in 2027).
Yes. The year-by-year max values show NMTC reaching $5.29 in 2034 and $5.59 in 2035, with higher upside in 2040 ($7.28) and 2050 ($13.33).
Current price is $1.76 and market cap is $15.32M. Its market rank is 4774.
RSI14 is 20, indicating oversold conditions. SMA50 is $3.23 and SMA200 is $4.29. Support is at $1.76 and resistance at $3.35. The 30-day trading range is $1.35 to $2.30, and the overall sentiment is NEUTRAL. Annualized volatility is 80%.
NeuroOne Medical Technologies Corporation Community Discussion
0Share your NeuroOne Medical Technologies Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.